Search results
2 kwi 2023 · The selection of empiric antibiotic therapy for the treatment of MRSA infection depends on the type of disease, local S. aureus resistance patterns, availability of the drug, side effect profile, and individual patient profile.
antibiotic susceptibility profiles for CA-MRSA to assist providers in choosing ap-propriate empiric antibiotic therapy. Given the lack of clear-cut guidelines for pharmacologically treating pa-tients who present with CA-MRSA at the time of our study, we con-ducted.
1 lut 2011 · For empirical coverage of CA-MRSA in outpatients with SSTI, oral antibiotic options include the following: clindamycin (A-II), trimethoprim-sulfamethoxazole (TMP-SMX) (A-II), a tetracycline (doxycycline or minocycline) (A-II), and linezolid (A-II).
26 sie 2024 · MRSA TREATMENT. If MRSA infection is diagnosed, you will be given an antibiotic. There are now a large number of antibiotics that can be successfully used to treat MRSA infections. The antibiotic dose or type may be changed when the results of the laboratory culture are available.
8 lut 2019 · Recent examples of emergent MRSA strains include the health-care-associated MRSA (HA-MRSA) clonal complex 30 (CC30) in North America and Europe, community-associated MRSA (CA-MRSA)...
29 lis 2023 · Methicillin resistance in Staphylococcus aureus (MRSA) is defined by the Clinical Laboratory Standards Institute (CLSI) as an oxacillin minimum inhibitory concentration (MIC) ≥4 mcg/mL [1].
All California general acute care hospitals are required to report MRSA bloodstream infection (BSI) cases that occur following hospitalization so that CDPH can calculate the rates of MRSA BSI at each hospital and make that information available to the public (Health and Safety Code Section 1288.55).
